nm23-M1基因在小鼠粒单核细胞白血病中的表达

doi:10.3969/j.issn.1674-5817.2014.01.008

摘要/Abstract

摘要： 目的探讨nm23-M1基因在小鼠粒单核细胞白血病中的表达。方法给小鼠经尾静脉注射粒单核细胞白血病细胞株WEHI-3, 同时选取正常小鼠作为对照组,取发病小鼠以及正常小鼠的骨髓, 采取qRT-PCR的方法检测nm23-M1基因的表达情况,分析其与白血病发生及发展的关系。结果粒单细胞白血病小鼠骨髓细胞中nm23-M1基因的相对表达量是正常对照组中的24倍, 两组之间有显著性差异(P<0.05)。结论 nm23-M1基因在小鼠粒单核细胞白血病中高表达, 并且与外周血白细胞数、骨髓原始细胞数以及脏器白血病侵袭情况相关,而与白血病小鼠的性别、年龄无关。

关键词: nm23-M1基因, 粒单核细胞白血病

Abstract: Objective To investigate the expression level of nm23-M1 gene in mouse myelomonocytic leukemia. Methods The mice were inoculated intravenously with myelomonocytic leukemia cells of WEHI-3 cells, and selected a control group of normal mice. Bone marrow samples were collected in two groups. The nm23-M1 mRNA expression were detected by TaqMan quantitative real-time reverse transcription polymerase chain reaction(qRT-PCR) and analysis of its relationship with the occurrence and development of leukemia. Results The expression of nm23-M1 gene in bone marrow cells of mice with leukemia is 24 times of the normal control group. There was a significant difference between the two groups (P<0.05). Conclusion The nm23-M1 gene overexpressed .in mouse myelomonocytic leukemia, and had close relationship between and peripheral white blood cell count, the number of original cells in bone marrow and organ against the leukemia cases, regardless of the gender, age and leukemia in mice.

Key words: nm23-M1 gene, Myelomonocytic leukemia

中图分类号:

Q95-33

董征,孙雪冬,满秋红,等. nm23-M1基因在小鼠粒单核细胞白血病中的表达[J]. 实验动物与比较医学, 2014, 34(1): 42-45. DOI: 10.3969/j.issn.1674-5817.2014.01.008.

DONG Zheng,SUN Xue-dong,MAN Qiu-hong,et al. Expression of nm23-M1 Gene in Mouse Myelomonocytic Leukemia[J]. Laboratory Animal and Comparative Medicine, 2014, 34(1): 42-45. DOI: 10.3969/j.issn.1674-5817.2014.01.008.

参考文献

[1] Steeg PS, Bevilacqua G, Kopper L, et al.Evidence for a novel gene associated with low tumor metastatic potential[J]. J Natl Cancer Inst, 1988,80(3):200-204.
[2] Chandrasekharappa SC, Gross LA, King SE, et al.The human NME2 gene lies within 18kb of NME1 in chrosome 17[J]. Gene Chromosomes Cancer, 1993, 6(4):245-248.
[3] Smagghe BJ, Stewart AK, Carter MG, et al.MUC1* Ligand, NM23-H1, is a novel growth factor that maintains human stem cells in a more naive state[J]. PLoS One,2013,8(3):e58601.
[4] Okabe-Kado J, Kasukabe T, Kaneko Y.Extracellular NM23 protein as a therapeutic target for hematologic malignancies[J]. Adv Hematol, 2012:879368.
[5] Joosten M, Blazquez-Domingo M, Lindeboom F, et al.Translational control of putative protooncogene Nm23-M2 by cytokines via phosphoinositide 3-kinase signaling[J]. J Biol Chem, 2004, 279(37):38169-38176.
[6] Okabe-Kado J, Kasukabe T, Honma Y.Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia[J]. Leuk Lymphoma, 1998, 32(1-2):19-28.
[7] An R, Meng J, Shi Q, et al.Expressions of nucleoside diphosphate kinase (nm23) in tumor tissues are related with metastasis and length of survival of patients with hepatocellular carcinoma[J]. Biomed Environ Sci, 2010, 23(4):267-272.
[8] Andolfo I, De Martino D, Liguori L, et al.Correlation of NM23-H1 cytoplasmic expression with metastatic stage in human prostate cancer tissue[J]. Naunyn Schmiedebergs Arch Pharmacol, 2011, 384(4-5):489-498.
[9] Liu C, Liu J, Wang X, et al.Prognostic impact of nm23-H1 and PCNA expression in pathologic stage I non-small cell lung cancer[J]. J Surg Oncol, 2011, 104(2):181-186.
[10] Boissan M, De Wever O, Lizarraga F, et al.Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells[J]. Cancer Res, 2010, 70(19):7710-7722.
[11] Lilly AJ, Khanim FL, Hayden RE, et al.Nm23-h1 indirectly promotes the survival of acute myeloid leukemia blast cells by binding to more mature components of the leukemic clone[J]. Cancer Res, 2011, 71(3):1177-1186.
[12] Niitsu N, Nakamine H, Okamoto M.Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma, not otherwise specified[J]. Clin Cancer Res,2011, 17(9):2893-2899.
[13] Niitsu N, Tamaru J, Yoshino T, et al.A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy[J]. Ann Hematol,2011, 90(2):185-192.
[14] Yokoyama A, Okabe-Kado J, Wakimoto N, et al.Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies[J]. Blood, 1998, 91(6):1845-1851.

[1]	张娇玲, 林阿萍, 许诗荧, 潘德全, 蔡毅君. 小鼠胚胎移植技术的优化及应用[J]. 实验动物与比较医学, 2026, (): 1-9.
[2]	孙强. 实验动物，还是实验用动物：非人灵长类动物的遗传组成差异[J]. 实验动物与比较医学, 2026, 46(4): 611-613.
[3]	李春杨, 刘星辰, 李玉琢, 陆勇, 王燕, 高长山, 聂艳红, 卞新颜, 胡超, 朱家桥, 孙强. BMPR1B^FecB 同源突变的食蟹猴与恒河猴模型构建[J]. 实验动物与比较医学, 2026, 46(4): 467-475.
[4]	李虹漫, 陈昱彤, 石英培, 王伊静, 潘言, 许童, 周艺, 邓其跃, 刘雪. 实验动物精神健康评估新视角：基于毛发特征的应激反应监测[J]. 实验动物与比较医学, 2026, 46(4): 553-563.
[5]	马文静, 刘燕萍, 李一帆, 郭欢, 谢理惠, 杜龙基, 马佳丽, 王红平, 黎家敏. GLP管理体系下实验动物设施消毒剂、饲料和垫料有效期管理实践[J]. 实验动物与比较医学, 2026, 46(4): 593-603.
[6]	李自发, 刘珊, 孙伟, 赵峰, 魏盛, 李琴, 徐凯勇. 实验动物学科教融合体系的思考与实践：以山东中医药大学为例[J]. 实验动物与比较医学, 2026, 46(4): 604-610.
[7]	强苏静, 李冬婷, 徐瑾华, 蔡莉, 韦思羽, 邹嘉镭, 丁玉强. 实验大鼠和小鼠中肺炎克雷伯菌复合体的鉴定与分析[J]. 实验动物与比较医学, 2026, 46(4): 564-572.
[8]	雷建军, 索晨浩, 张贺. 白藜芦醇通过调控CCL3/CCR5信号通路减轻脑缺血再灌注大鼠模型的血脑屏障损伤[J]. 实验动物与比较医学, 2026, 46(4): 487-497.
[9]	王璐, 王青杰, 杨春弘, 张一鉴. 动物替代新方法学在生物医学领域的应用及其对“3R”原则的践行[J]. 实验动物与比较医学, 2026, 46(4): 573-582.
[10]	龚志群, 饶希午, 张天弋, 吴荣琛, 叶明楠, 蒋春曦, 王苏美, 朱燕娟, 柴小姝. 免疫检查点抑制剂相关性肺炎小鼠模型的构建与评价[J]. 实验动物与比较医学, 2026, 46(4): 498-506.
[11]	刘亮, 陈兵, 孟黎, 张欢, 刘晋州, 刘科亮, 李阳友, 段佳慧, 严锦泰, 杨国淋, 金波. 服务国家战略与成渝地区生物医药产业：实验动物学本科教育的创新布局与实践路径[J]. 实验动物与比较医学, 2026, (): 1-12.
[12]	杨然, 冯戟玮, 马飞, 张玉, 刘智伟, 金立伦. 秦皮素通过Nrf2/HO-1信号通路抑制铁死亡减轻骨关节炎大鼠软骨损伤[J]. 实验动物与比较医学, 2026, (): 1-12.
[13]	艾秀峰, 张利棕, 方明笋, 吕东颖, 陈楚, 蔡兆伟, 王德军. 16S rRNA测序分析饮用含氯水对大鼠和小鼠肠道菌群的影响差异[J]. 实验动物与比较医学, 2026, 46(3): 437-445.
[14]	周忆旻, 张昕宇, 杨佳诺, 刘梦佳, 司灿灿, 叶海绿, 孙文超, 兰添. MHV、MPV和Reo-3三重TaqMan定量PCR检测方法的建立[J]. 实验动物与比较医学, 2026, 46(3): 408-415.
[15]	孙强. 克隆能否让哺乳动物“永生”：20年58代小鼠给出的回答[J]. 实验动物与比较医学, 2026, 46(3): 464-466.